Literature DB >> 18677571

Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.

Xiaobin Zhang1, Daria Y Alakhova, Elena V Batrakova, Shu Li, Zhihui Yang, Yili Li, Alexander V Kabanov.   

Abstract

A synthetic amphiphilic block copolymer Pluronic P85 (P85) was shown to be among the most potent inhibitors of Pgp efflux system in the blood-brain barrier (BBB) and capable of enhancing delivery of Pgp substrates to the brain. The purpose of this work is to evaluate the effects of P85 on amino acid transport in BBB. Primary bovine brain microvessel endothelial cells (BBMEC) grown on membrane inserts were used as an in vitro BBB model. Expression of amino acid transporters, like large neutral amino acid transporter 1, cationic amino acid transporter 1, and small neutral amino acid transporter 1, were confirmed by reverse transcriptase polymerase chain reaction. Effects of P85 on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively. BBMEC permeability studies were carried out in apical (AP) to basolateral (BL) and BL to AP directions. P85 added at the AP side had little, if any, effect on AP to BL ("blood to brain") transport for all examined amino acids in BBMEC monolayers. However, 0.1% P85 added at the BL side significantly increased the BL to AP transport of these substrates. Furthermore, the effective concentrations of P85 were also shown to induce plasma membrane depolarization and increase intracellular sodium concentration in BBMEC, which can contribute to the effects of the copolymer on the energy-dependent transport systems. All together, despite profound effects on transport system(s) at the brain side of cell monolayers, P85 had no effect on AP to BL transport of amino acids in brain microvessel endothelial cell model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677571      PMCID: PMC2644348          DOI: 10.1007/s11481-008-9119-1

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  28 in total

1.  Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+.

Authors:  Robyn L O'Kane; Juan R Viña; Ian Simpson; Rosa Zaragozá; Ashwini Mokashi; Richard A Hawkins
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-03-28       Impact factor: 4.310

2.  Two mechanisms by which fluorescent oxonols indicate membrane potential in human red blood cells.

Authors:  P R Pratap; T S Novak; J C Freedman
Journal:  Biophys J       Date:  1990-04       Impact factor: 4.033

3.  Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells.

Authors:  Yadollah Omidi; Jaleh Barar; Somaieh Ahmadian; Hamid Reza Heidari; Mark Gumbleton
Journal:  Cell Biochem Funct       Date:  2008-04       Impact factor: 3.685

Review 4.  Structure of the blood-brain barrier and its role in the transport of amino acids.

Authors:  Richard A Hawkins; Robyn L O'Kane; Ian A Simpson; Juan R Viña
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

5.  Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.

Authors:  M M Nerurkar; N F Ho; P S Burton; T J Vidmar; R T Borchardt
Journal:  J Pharm Sci       Date:  1997-07       Impact factor: 3.534

6.  An active transport system in the blood-brain barrier may reduce levodopa availability.

Authors:  Richard A Hawkins; Ashwini Mokashi; Ian A Simpson
Journal:  Exp Neurol       Date:  2005-09       Impact factor: 5.330

7.  Identification of the cationic amino acid transporter (System y+) of the rat blood-brain barrier.

Authors:  J Stoll; K C Wadhwani; Q R Smith
Journal:  J Neurochem       Date:  1993-05       Impact factor: 5.372

8.  Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.

Authors:  E V Batrakova; S Li; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

9.  Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization.

Authors:  E V Batrakova; S Li; S V Vinogradov; V Y Alakhov; D W Miller; A V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

10.  Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells.

Authors:  Elena V Batrakova; Shu Li; Valery Yu Alakhov; Donald W Miller; Alexander V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

View more
  3 in total

1.  Nanobiology for the pharmacology of cellular ion channels.

Authors:  Alexander V Kabanov; Mikhail P Kirpichnikov; Alexey R Khokhlov
Journal:  J Neuroimmune Pharmacol       Date:  2009-01-24       Impact factor: 4.147

Review 2.  Brain delivery of proteins via their fatty acid and block copolymer modifications.

Authors:  Xiang Yi; Alexander V Kabanov
Journal:  J Drug Target       Date:  2013-12       Impact factor: 5.121

Review 3.  Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches.

Authors:  Carolina Velasco-Aguirre; Francisco Morales; Eduardo Gallardo-Toledo; Simon Guerrero; Ernest Giralt; Eyleen Araya; Marcelo J Kogan
Journal:  Int J Nanomedicine       Date:  2015-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.